Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington dials in from the Jefferies London Healthcare Conference to tell Proactive that a consortium led by Poolbeg has been awarded €2.3m in non-dilutive grant funding from the Irish government. The money will be used to support the development of an oral vaccine platform that will make it easier to "generate numerous oral vaccines" in the future.
Skillington describes the challenge of developing an oral vaccine that is able to survive for enough time inside the body to take effect, and says there are "lots of benefits for oral vaccines over injections."